Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations.

Peter M Calverley; Dirkje S Postma; Antonio R Anzueto; Barry J Make; Göran Eriksson; Stefan Peterson; Christine R Jenkins

doi:10.2147/COPD.S93303

Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations.

Peter M Calverley, Dirkje S Postma, Antonio R Anzueto, Barry J Make, Göran Eriksson, Stefan Peterson, Christine R Jenkins

Respiratory Medicine, Allergology, and Palliative Medicine

Skåne University Hospital

Research output: Contribution to journal › Article › peer-review

Abstract

Early treatment response markers, for example, improvement in forced expiratory volume in 1 second (FEV1) and St George's Respiratory Questionnaire (SGRQ) total score, may help clinicians to better manage patients with chronic obstructive pulmonary disease (COPD). We investigated the prevalence of clinically important improvements in FEV1 and SGRQ scores after 2-month budesonide/formoterol or formoterol treatment and whether such improvements predict subsequent improvements and exacerbation rates.

Original language	English
Pages (from-to)	381-390
Journal	The International Journal of Chronic Obstructive Pulmonary Disease
Volume	11
DOIs	https://doi.org/10.2147/COPD.S93303
Publication status	Published - 2016

Subject classification (UKÄ)

Respiratory Medicine and Allergy

Access to Document

10.2147/COPD.S93303

http://www.ncbi.nlm.nih.gov/pubmed/26952309?dopt=Abstract

Cite this

Calverley, P. M., Postma, D. S., Anzueto, A. R., Make, B. J., Eriksson, G., Peterson, S., & Jenkins, C. R. (2016). Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations. The International Journal of Chronic Obstructive Pulmonary Disease, 11, 381-390. https://doi.org/10.2147/COPD.S93303

@article{a59be422567641aeadf682b459adc212,

title = "Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations.",

abstract = "Early treatment response markers, for example, improvement in forced expiratory volume in 1 second (FEV1) and St George's Respiratory Questionnaire (SGRQ) total score, may help clinicians to better manage patients with chronic obstructive pulmonary disease (COPD). We investigated the prevalence of clinically important improvements in FEV1 and SGRQ scores after 2-month budesonide/formoterol or formoterol treatment and whether such improvements predict subsequent improvements and exacerbation rates.",

author = "Calverley, {Peter M} and Postma, {Dirkje S} and Anzueto, {Antonio R} and Make, {Barry J} and G{\"o}ran Eriksson and Stefan Peterson and Jenkins, {Christine R}",

year = "2016",

doi = "10.2147/COPD.S93303",

language = "English",

volume = "11",

pages = "381--390",

journal = "The International Journal of Chronic Obstructive Pulmonary Disease",

issn = "1178-2005",

publisher = "Dove Medical Press Ltd.",

}

Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations. / Calverley, Peter M; Postma, Dirkje S; Anzueto, Antonio R et al.
In: The International Journal of Chronic Obstructive Pulmonary Disease, Vol. 11, 2016, p. 381-390.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations.

AU - Calverley, Peter M

AU - Postma, Dirkje S

AU - Anzueto, Antonio R

AU - Make, Barry J

AU - Eriksson, Göran

AU - Peterson, Stefan

AU - Jenkins, Christine R

PY - 2016

Y1 - 2016

N2 - Early treatment response markers, for example, improvement in forced expiratory volume in 1 second (FEV1) and St George's Respiratory Questionnaire (SGRQ) total score, may help clinicians to better manage patients with chronic obstructive pulmonary disease (COPD). We investigated the prevalence of clinically important improvements in FEV1 and SGRQ scores after 2-month budesonide/formoterol or formoterol treatment and whether such improvements predict subsequent improvements and exacerbation rates.

AB - Early treatment response markers, for example, improvement in forced expiratory volume in 1 second (FEV1) and St George's Respiratory Questionnaire (SGRQ) total score, may help clinicians to better manage patients with chronic obstructive pulmonary disease (COPD). We investigated the prevalence of clinically important improvements in FEV1 and SGRQ scores after 2-month budesonide/formoterol or formoterol treatment and whether such improvements predict subsequent improvements and exacerbation rates.

U2 - 10.2147/COPD.S93303

DO - 10.2147/COPD.S93303

M3 - Article

C2 - 26952309

SN - 1178-2005

VL - 11

SP - 381

EP - 390

JO - The International Journal of Chronic Obstructive Pulmonary Disease

JF - The International Journal of Chronic Obstructive Pulmonary Disease

ER -

Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations.

Abstract

Subject classification (UKÄ)

Access to Document

Fingerprint

Cite this